HDL Cholesterol

HDL-C is the cholesterol carried in high-density lipoprotein particles, popularly called 'good cholesterol' because higher levels are associated with lower cardiovascular risk.

HDL-C is a useful risk marker, but it is important to read it correctly: raising HDL with drugs (niacin, CETP inhibitors) has not reduced cardiovascular events, and genetic studies do not support HDL as causal. It reflects risk; it is not something to be pushed higher for its own sake.

1. 1

   FoundationCardiovascular HealthThe best place to understand what actually prevents heart disease.
2. 2

   ConditionMetabolic SyndromeA cluster of risks that travel together
3. 3

   Signal RecordOmega-3 Fatty AcidsFish Oil / EPA + DHA
4. 4

   Body SystemCardiovascularHeart function, blood pressure, and circulatory health.

1. Measure it
2. Understand your result
3. See what raises and lowers it
4. Apply evidence-based interventions
5. Recheck on your review cadence

An orientation to how this topic is typically approached — not medical advice.

Low HDL-C often accompanies insulin resistance, obesity, and high triglycerides and flags higher cardiometabolic risk. Unusually high HDL-C does not confer extra protection and, at the extremes, may associate with paradoxically higher risk.

• Standard lipid panel

HDL-C is a robust risk marker but, unlike LDL/ApoB, is not a validated causal target — a key anti-hype distinction supported by failed HDL-raising trials and Mendelian randomization.

• AHA Scientific Statements on HDL
• 2019 ESC/EAS Dyslipidaemia Guidelines
• Mendelian randomization studies of HDL

Sources are named authoritative guidelines and scientific bodies. Biomarker pages present established clinical context; calibrated evidence verdicts on specific interventions live in the linked Signal Records.